Funder: DARPA - Biological Technologies Office

Due Dates: March 9, 2026 (Questions) | March 12, 2026 (Gate 1: Video Abstract & Abbreviated Technical Volume) | May 7, 2026 (Gate 2: Full Proposal)

Funding Amounts: Award size determined by proposal scope; multiple awards anticipated; period of performance is 33 months.

Summary: Supports research to develop novel medical countermeasures that restore protein function against chemical threat agents.

Key Information: Two-stage submission: video abstract & abbreviated technical volume required for Gate 1; full proposals by invitation only.